Determinants of quality of life in bronchiectasis using the quality of life bronchiectasis (QOL-B) questionnaire: data from the EMBARC registry

E. Polverino (Barcelona, Spain), F. Blasi (MIlano, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (New Castle, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Leuven, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milano, Italy), J. Chalmers (Dundee, United Kingdom)

Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies
Session: Bronchiectasis: phenotypes, endotypes and new therapies
Session type: Oral Presentation
Number: 4951
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Polverino (Barcelona, Spain), F. Blasi (MIlano, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (New Castle, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Leuven, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milano, Italy), J. Chalmers (Dundee, United Kingdom). Determinants of quality of life in bronchiectasis using the quality of life bronchiectasis (QOL-B) questionnaire: data from the EMBARC registry. 4951

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment of quality of life in patients with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Health-related quality of life and hospitalisations for COPD exacerbations: validity of the Romanian version of the clinical COPD questionnaire
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Determinants of health-related quality of life (HRQL) in patients with COPD
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008

Assessing health-related quality of life in COPD: A comparison between one generic and two disease-specific instruments
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

Can disease-specific questionnaires describe the effect of comorbidities on health-related quality of life in patients with COPD? A comparison of disease-specific and generic questionnaires in the COSYCONET cohort
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016


Predictors of health-related quality of life using sf-12 questionnaire, in Greek COPD outpatients
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009


Costs and health-related quality of life in COPD patients with a-1-antitrypsin deficiency: results of the COSYCONET cohort
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Pulmonary rehabilitation outcome: quality of life (QoL) and COPD severity
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004

Factors associated with quality of life measured by EQ-5D in Korean COPD patients
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013

Health-related quality of life (HRQL) and asthma control in the EGEA2 study
Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Year: 2008

Health-related quality of life in emphysema due to alpha-1-antitrypsin deficiency
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013



Treatment patterns in primary care: European health-related quality of life in COPD study
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010


Does panic predict health-related quality of life (HRQoL) in COPD? A longitudinal cohort study
Source: International Congress 2014 – Respiratory disease management in primary care
Year: 2014

The effect of COPD and FEV1 decline on health-related quality of life: A longitudinal, population-based study
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year
Source: Eur Respir J 2010; 35: 1022-1030
Year: 2010



Quality of life (QOL) and clinical phenotypes in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 809s
Year: 2006

What predicts a deterioration of generic and disease-specific health-related quality of life in COPD? First longitudinal results of the COSYCONET cohort
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Health-related quality of life and psychological distress in patients with COPD: 3-year-follow-up
Source: Annual Congress 2008 - Issues in the management of COPD in the community
Year: 2008


Assesment of quality of life in patients with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 284s
Year: 2004

Health-related quality of life questionnaires in bronchiectasis: the simplest way to quantify complexity
Source: Eur Respir J, 49 (5) 1700208; 10.1183/13993003.00208-2017
Year: 2017